MediciNova appoints Nicole Lemerond to Board, filling vacancy

MEDICINOVA INC

Lemerond appointed as Class I director, term expiring at 2026 Annual Meeting.
She joins Audit, Compensation, and Nominating Committees immediately.
Granted option to purchase 18,333 shares vesting quarterly through June 30, 2024.
Lemerond is former Managing Partner of NV Capital (2010-2022) with 25+ years in healthcare finance.
No family relationships or material transactions with existing directors or officers.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nicole Lemerond

Member of the Board

MNOV · MEDICINOVA INC

Effective: 2023-08-04
Filed: August 7, 2023, 7:59 PM ET

On August 4, 2023, the Board of Directors (the “Board”) of MediciNova, Inc. (the “Company”) appointed Nicole Lemerond as a member of the Board, effective immediately, filling an existing vacancy on the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicole Lemerond was appointed as Member of the Board at MEDICINOVA INC.

Action: appointed
Role: Member of the Board

Exact text from the filing

On August 4, 2023, the Board of Directors (the “Board”) of MediciNova, Inc. (the “Company”) appointed Nicole Lemerond as a member of the Board, effective immediately, filling an existing vacancy on the Board.

View on SEC.gov

MEDICINOVA INC filing history →

Source: SEC EDGAR

accession 0001193125-23-204956

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.